Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
31.04
+3.53 (12.83%)
At close: Feb 27, 2026, 4:00 PM EST
31.17
+0.13 (0.42%)
After-hours: Feb 27, 2026, 7:56 PM EST

Nanobiotix Revenue

Nanobiotix had revenue of 13.32M EUR in the half year ending June 30, 2025, with 186.77% growth. This brings the company's revenue in the last twelve months to 10.16M, down -75.93% year-over-year. In the year 2024, Nanobiotix had annual revenue of -7.19M.

Revenue (ttm)
10.16M EUR
Revenue Growth
-75.93%
P/S Ratio
123.75
Revenue / Employee
98,621 EUR
Employees
103
Market Cap
1.48B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024-7.19M-43.40M-
Dec 31, 202336.21M31.43M658.10%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M135.00K5.37%
Dec 31, 20202.51M-29.00K-1.14%
Dec 31, 20192.54M-938.00K-26.96%
Dec 31, 20183.48M-243.00K-6.53%
Dec 31, 20173.72M-1.70M-31.35%
Dec 31, 20165.42M1.41M35.03%
Dec 31, 20154.02M1.24M44.91%
Dec 31, 20142.77M1.18M73.67%
Dec 31, 20131.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AnaptysBio169.47M
Vir Biotechnology68.56M
Tango Therapeutics66.50M
EyePoint42.34M
Zenas BioPharma15.00M
Capricor Therapeutics11.13M
Revenue Rankings